For the Inventor, By the Inventor

Enter inventor name

Dordrecht, Netherlands

Judith Christina Theodora Van Deutekom

USPTO Granted Patents = 23 (Patent Applications = 38)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 26 (Patent Applications = 37)

Average Co-Inventor Count = 2.3

ph-index = 13

Forward Citations = 585(Granted Patents)

Company Filing History:

Academisch Ziekenhuis Leiden

Biomarin Technologies B.v.

Prosensa Technologies B.v.

Prosena Technologies B.v.

Academisch Ziekenhuis Leiden (h.o.d.n. Lumc)

Academisch Ziekenbuls Leiden

7. 1 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

Loading Chart...

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331293 - Bispecific antisense oligonucleotides for dystrophin exon skipping (2025-06-17),

2. 11634714 - Oligonucleotide comprising an inosine for treating DMD (2023-04-25),

3. 11427820 - Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA (2022-08-30),

4. 11034956 - Oligonucleotide comprising an inosine for treating DMD (2021-06-15),

5. RE48468 - Means and methods for counteracting muscle disorders (2021-03-15),

6. 10913946 - RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy (2021-02-09),

7. 10876114 - Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 50-53 (2020-12-29),

8. 10533171 - Oligonucleotide comprising an inosine for treating DMD (2020-01-14),

9. 10246707 - Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means (2019-04-02),

10. 10190116 - Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure (2019-01-29),

11. 10179912 - RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy (2019-01-15),

12. 10113165 - Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure (2018-10-30),

13. 10100304 - Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure (2018-10-16),

14. 9926557 - Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA (2018-03-27),

15. 9896687 - Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure (2018-02-20),

Title: Judith Christina Theodora Van Deutekom: Innovator in Genetic Research

Introduction

Judith Christina Theodora Van Deutekom is a prominent inventor based in Dordrecht, Netherlands. Known for her groundbreaking work in genetic research, she holds an impressive 22 patents, reflecting her significant contributions to the scientific community.

Latest Patents

Among her latest patents is an invention featuring an oligonucleotide that includes an inosine for treating Duchenne Muscular Dystrophy (DMD). This oligonucleotide comprises a sequence that is complementary to portions of dystrophin pre-mRNA, offering a potential method for treating DMD and Becker Muscular Dystrophy (BMD). Another notable patent describes a method for inducing the skipping of exon 45 in DMD pre-mRNA, which involves using an antisense molecule to bind to a specific nucleotide stretch within the exon, providing a therapeutic approach for affected patients.

Career Highlights

Throughout her career, Judith has worked with esteemed organizations, including the Academic Hospital Leiden and BioMarin Technologies B.V. These roles have allowed her to advance her research and apply her innovations to real-world medical challenges.

Collaborations

Judith Van Deutekom has collaborated with several notable professionals in her field, including Josephus Johannes De Kimpe and Gerard Johannes Platenburg. These partnerships have fostered a collaborative environment that enhances the development and application of her patented technologies.

Conclusion

Judith Christina Theodora Van Deutekom exemplifies innovation in genetic research, with her patents paving the way for new treatments for muscular dystrophies. Her dedication to advancing science through collaboration and invention continues to have a profound impact on medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…